1. Norway Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 72
Price: Single User License – US$2500
Norway Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Summary
Global Markets Direct’s new report, “Norway Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018” provides key market data on the Norway Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Norway Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi , Novo Nordisk A/S , Eli Lilly and
Company , Medtronic, Inc., LifeScan, Inc.and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Norway Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/195383-norway-diabetes-care-devices-investment-opportunities-analysis-
and-forecasts-to-2018.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Norway 8
3.1 Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Norway, Company Share (2010-2011) 13
4 Glucose Monitoring In Norway 15
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 15
4.1.1 Blood Glucose Meters, Norway, Revenue (2004-2018) 19
4.2 Glucose Monitoring Overall Volume (2004-2018) 23
4.2.1 Blood Glucose Meters, Norway, Volume (2004-2018) 27
4.3 Glucose Monitoring Average Price (2004-2018) 30
4.4 Glucose Monitoring Distribution Share (2010-2011) 31
4.5 Glucose Monitoring, Norway, Company Share (2010-2011) 32
5 Insulin Delivery In Norway 34
5.1 Insulin Delivery Overall Revenue, (2004-2018) 34
5.1.1 Insulin Pens, Norway, Revenue (2004-2018) 38
5.1.2 Insulin Pumps, Norway, Revenue (2004-2018) 42
5.2 Insulin Delivery Overall Volume (2004-2018) 46
5.2.1 Insulin Pens, Norway, Volume (2004-2018) 50
5.2.2 Insulin Pumps, Norway, Volume (2004-2018) 54
5.3 Insulin Delivery Average Price (2004-2018) 57
5.4 Insulin Delivery Distribution Share (2010-2011) 58

3. 5.5 Insulin Delivery, Norway, Company Share (2010-2011) 59
6 Overview of Key Companies in Norway Diabetes Care Devices Market 61
6.1 F. Hoffmann-La Roche Ltd. 61
6.1.1 Company Overview 61
6.2 Sanofi 61
6.2.1 Company Overview 61
6.3 Novo Nordisk A/S 62
6.3.1 Company Overview 62
6.4 Eli Lilly and Company 62
6.4.1 Company Overview 62
6.5 LifeScan, Inc. 62
6.5.1 Company Overview 62
6.6 Medtronic, Inc. 63
6.6.1 Company Overview 63
6.7 Becton, Dickinson and Company 63
6.7.1 Company Overview 63
6.8 Animas Corporation 63
6.8.1 Company Overview 63
6.9 Bayer HealthCare AG 64
6.9.1 Company Overview 64
6.10 Abbott Laboratories 64
6.10.1 Company Overview 64
6.11 Ypsomed Holding AG 64
6.11.1 Company Overview 64
6.12 Terumo Corporation 65
6.12.1 Company Overview 65
6.13 Nipro Corporation 65
6.13.1 Company Overview 65
7 Appendix 66
7.1 Global Markets Direct Research Methodology 66
7.2 Definitions of Markets Covered in the Report 67
7.2.1 Diabetes Care Devices 67
7.3 Secondary Research 70
7.4 Primary Research 70
7.5 Models 71
7.6 Forecasts 71
7.7 Expert Panel Validation 71
7.8 Currency Conversion 72
7.9 Contact Us 72
7.10 Disclaimer 72
1.1 List of Tables

4. Table 1: Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 8
Table 2: Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 10
Table 3: Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 12
Table 4: Diabetes Care Devices, Norway, Company Share by Revenue ($m), USD Constant,
2010-2011 14
Table 5: Glucose Monitoring, Norway, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 16
Table 6: Glucose Monitoring, Norway, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 18
Table 7: Blood Glucose Meters, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Historic, 2004-2011 20
Table 8: Blood Glucose Meters, Norway, Revenue ($m*) USD Constant, by Sub-Segment,
Forecast, 2011-2018 22
Table 9: Glucose Monitoring, Norway, Volume (Units) by Segment, Historic, 2004-2011 24
Table 10: Glucose Monitoring, Norway, Volume (Units) by Segment, Forecast, 2011-2018 26
Table 11: Blood Glucose Meters, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011
28
Table 12: Blood Glucose Meters, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018
29
Table 13: Glucose Monitoring, Norway, Average Price ($), Historic, 2004-2011 30
Table 14: Glucose Monitoring, Norway, Average Price ($), Forecast, 2011-2018 30
Table 15: Glucose Monitoring, Norway, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 31
Table 16: Glucose Monitoring, Norway, Company Share by Revenue ($m), USD Constant, 2010-
2011 33
Table 17: Insulin Delivery, Norway, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 35
Table 18: Insulin Delivery, Norway, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 37
Table 19: Insulin Pens, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 39
Table 20: Insulin Pens, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 41
Table 21: Insulin Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 43
Table 22: Insulin Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 45
Table 23: Insulin Delivery, Norway, Volume (Units) by Segment, Historic, 2004-2011 47
Table 24: Insulin Delivery, Norway, Volume (Units) by Segment, Forecast, 2011-2018 49
Table 25: Insulin Pens, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 51

5. Table 26: Insulin Pens, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 53
Table 27: Insulin Pumps, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 55
Table 28: Insulin Pumps, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 56
Table 29: Insulin Delivery, Norway, Average Price ($), Historic, 2004-2011 57
Table 30: Insulin Delivery, Norway, Average Price ($), Forecast, 2011-2018 57
Table 31: Insulin Delivery, Norway, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 58
Table 32: Insulin Delivery, Norway, Company Share by Revenue ($m), USD Constant, 2010-2011
60
1.2 List of Figures
Figure 1: Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 9
Figure 3: Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 11
Figure 4: Diabetes Care Devices, Norway, Company Share (%) 2011 13
Figure 5: Glucose Monitoring, Norway, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 15
Figure 6: Glucose Monitoring, Norway, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 17
Figure 7: Blood Glucose Meters, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 19
Figure 8: Blood Glucose Meters, Norway, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 21
Figure 9: Glucose Monitoring, Norway, Volume (Units) by Segment, Historic, 2004-2011 23
Figure 10: Glucose Monitoring, Norway, Volume (Units) by Segment, Forecast, 2011-2018 25
Figure 11: Blood Glucose Meters, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011
27
Figure 12: Blood Glucose Meters, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018
29
Figure 13: Glucose Monitoring, Norway, Company Share (%), 2011 32
Figure 14: Insulin Delivery, Norway, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 34
Figure 15: Insulin Delivery, Norway, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 36
Figure 16: Insulin Pens, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 38
Figure 17: Insulin Pens, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 40
Figure 18: Insulin Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 42

6. Figure 19: Insulin Pumps, Norway, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 44
Figure 20: Insulin Delivery, Norway, Volume (Units) by Segment, Historic, 2004-2011 46
Figure 21: Insulin Delivery, Norway, Volume (Units) by Segment, Forecast, 2011-2018 48
Figure 22: Insulin Pens, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 50
Figure 23: Insulin Pens, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 52
Figure 24: Insulin Pumps, Norway, Volume (Units) by Sub-Segment, Historic, 2004-2011 54
Figure 25: Insulin Pumps, Norway, Volume (Units) by Sub-Segment, Forecast, 2011-2018 56
Figure 26: Insulin Delivery, Norway, Company Share (%), 2011 59
Figure 27: Global Markets Direct Methodology 66
Contact: sales@reportsandreports.com for more information.